Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

Publisher Name :
Date: 31-Oct-2018
No. of pages: 284
Inquire Before Buying

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, "Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Large Cell Lymphoma (ALCL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials 34
Prominent Drugs 36
Clinical Trial Profile Snapshots 38
Appendix 289
Abbreviations 289
Definitions 289
Research Methodology 290
Secondary Research 290
About GlobalData 291
Contact Us 291
Disclaimer 291
Source 292

List of Tables
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, E7 Countries (%), 2018* 21
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials, E7 Countries (%), 2018* 21
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 290
  • Global Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 03-Apr-2020        Price: US 3900 Onwards        Pages: 129
    This report focuses on the global Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Cell Lung Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Sanofi - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Ziopharm Oncology - ......
  • Global Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Research Report 2015-2025
    Published: 03-Apr-2020        Price: US 1800 Onwards        Pages: 80
    Summary The global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share......
  • Global Melanoma Therapeutics Market Size, Status and Forecast 2020-2026
    Published: 02-Apr-2020        Price: US 3900 Onwards        Pages: 97
    This report focuses on the global Melanoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Melanoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AstraZeneca - Amgen, Inc. - F. Hoffmann-La Roche Ltd. - Bristol-Myers Squibb Company - Novartis AG - Merck & ......
  • Global Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Status and Future Forecast 2015-2025
    Published: 31-Mar-2020        Price: US 4500 Onwards        Pages: 122
    Summary The report forecast global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leadin......
  • 2015-2027 Global Cancer Gene Therapy Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 31-Mar-2020        Price: US 3460 Onwards        Pages: 122
    The worldwide market for Cancer Gene Therapy is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the drivin......
  • Global Breast Cancer Monoclonal Antibodies Market Status and Future Forecast 2015-2025
    Published: 30-Mar-2020        Price: US 4500 Onwards        Pages: 155
    Summary The report forecast global Breast Cancer Monoclonal Antibodies market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Breast Cancer Monoclonal Antibodies industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Breast Cancer Monoclonal Antibodies by geography. Th......
  • Small Molecule Targeted Cancer Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Mar-2020        Price: US 3000 Onwards        Pages: 147
    Small Molecule Targeted Cancer Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Small Molecule Targeted Cancer Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Small Molecule Targeted Cancer Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides a......
  • Global Circulating Tumor Cells Market Status and Future Forecast 2015-2025
    Published: 20-Mar-2020        Price: US 4500 Onwards        Pages: 166
    Summary This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others). The report forecast global Circulating Tumor Cells market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Circulating Tumor Cells industry and main mark......
  • Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 13-Mar-2020        Price: US 3000 Onwards        Pages: 135
    Endometrial Cancer Treatments Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Endometrial Cancer Treatments industry with a focus on the Chinese market. The report provides key statistics on the market status of the Endometrial Cancer Treatments manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs